1[1]Kaplan N M. Diuretics:correct use in hypertension. Semin Nephrol,1999,19(6):569～574
2[2]Ambrosioni E, Safar M, Degaute J P, et al. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide:results of randomized double-blind controlled studies. J Hypertens,1998,16(11):1677～1684
3[3]Raskin P, Guthrie R, Flack J, et al. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide. J Hum Hypertens,1999,13(10):683～687
4[4]McClellan K J, Markham A. Perindopril 2 mg/indapamide 0.625 mg. Fixed low-dose combination. Drugs,1999,58(2):297～302
5[5]Curb J D, Pressel S L, Cutler J A, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA,1996,276(25):1886～1892
6[6]Psaty B M, Smith N L, Siscovick D S, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. JAMA,1997,277(9):739～745
7[7]Madkour H, Gadalah M, Riveline B, et al. Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. Am J Nephrol,1995,15(3):251～255
8[8]Donnelly R. Clinical implications of indapamide sustained release 1.5 mg in hypertension. Clin Pharmacokinet,1999,37(Suppl 1):S21～S32
9[9]Horl W H. Renaissance of diuretics in the treatment of hypertension. Wien Klin Wochenschr,1999,111(21):903～907
10[10]Shetty M A, Hegde B M. Principles of drug therapy in hypertension. J Indian Med Assoc,1999,97(3):106～109
